Projects
We address the aims of the Clinical Research Unit KFO309 within ten different projects
-
Profiling anti-influenza activities of the pathogen recognition receptor RIG-I: Novel targets for antiviral intervention strategies
-
Targeting immunophilin- and MAPK-associated pathways to inhibit MERS-CoV replication and prevent inflammatory lung injury
-
Virus-host interactions that drive and control airway epithelial injury in coronavirus infections
-
Role and regulation of alveolar protein clearance in influenza virus-induced lung injury
-
Susceptibility to viral infection driving lung injury and disruption of lung development in neonates with bronchopulmonary dysplasia
-
Role of epithelial endoplasmic reticulum stress and epithelial FGF signaling in the initiation and aggravation of lung fibrosis by viral infection
-
Novel strategies for therapeutic programming and delivery of mesenchymal stem cells to improve outcome of influenza virus-induced lung injury
-
Inhaled GM-CSF in CAP-associated ARDS: Analyses of GM-CSF-induced regenerative signatures in the alveolar compartment from patients with viral pneumonia included in the GI-HOPE study
-
Mitochondrial T-Cell reprogramming in virus-induced COPD exacerbation/emphysema progression
-
Core unit “Genome signatures and integrated systems biology of pathogen-host interaction and cellular networks in the infected and injured lung”